☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
richter
Richter Signs a License Agreement with Hikma to Commercialize Denosumab, a Proposed Biosimilar of Prolia and Xgeva in the US
December 9, 2021
PharmaShots Weekly Snapshot (Nov 30 - Dec 04, 2020)
December 4, 2020
Insights+ Key Biosimilars Events of April 2020
May 8, 2020
Gedeon Richter Signs an Asset Purchase Agreement with Mycenax for Biosimilar Tocilizumab to Treat Rheumatoid Arthritis
April 29, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
